Patent ID: 8222390
Filing Date: 2012-07-17
Classification: C12Q

Abstract:
1. A biomarker consisting of between 4 and 35 different nucleic acid probe sets, wherein: (a) a first probe set consists of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of SEQ ID NO:3(BLCAP), or a full complement thereof; (b) a second probe set consists of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of SEQ ID NO:4 (TH1L), or a full complement thereof; (c) a third probe set consists of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of SEQ ID NO:9 (HIST1H2BK), SEQ ID NO:3 (BLCAP), or a full complement thereof; and (d) a fourth probe set consists of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of one of SEQ ID NO:5 (UBE2G1) or SEQ ID NO:6 (CALM3), or a full complement thereof; wherein each of the between 4 and 35 different probe sets consists of one or more probes of 15 or more contiguous nucleotides, or full complements thereof, of a different mRNA, and wherein each of the different probe sets is optionally detectably labeled.